These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 10908000

  • 1. History of the methamphetamine problem.
    Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S.
    J Psychoactive Drugs; 2000; 32(2):137-41. PubMed ID: 10908000
    [Abstract] [Full Text] [Related]

  • 2. Methamphetamine abuse: issues for special populations.
    Freese TE, Obert J, Dickow A, Cohen J, Lord RH.
    J Psychoactive Drugs; 2000; 32(2):177-82. PubMed ID: 10908005
    [Abstract] [Full Text] [Related]

  • 3. A multisite study of the effectiveness of methamphetamine treatment: an initiative of the Center for Substance Abuse Treatment.
    Herrell JM, Taylor JA, Gallagher C, Dawud-Noursi S.
    J Psychoactive Drugs; 2000; 32(2):143-7. PubMed ID: 10908001
    [Abstract] [Full Text] [Related]

  • 4. A comparison of injecting and noninjecting methamphetamine users.
    Domier CP, Simon SL, Rawson RA, Huber A, Ling W.
    J Psychoactive Drugs; 2000; 32(2):229-32. PubMed ID: 10908012
    [Abstract] [Full Text] [Related]

  • 5. The matrix model of outpatient stimulant abuse treatment: history and description.
    Obert JL, McCann MJ, Marinelli-Casey P, Weiner A, Minsky S, Brethen P, Rawson R.
    J Psychoactive Drugs; 2000; 32(2):157-64. PubMed ID: 10908003
    [Abstract] [Full Text] [Related]

  • 6. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R.
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [Abstract] [Full Text] [Related]

  • 7. Treatment-as-usual in the methamphetamine treatment project.
    Galloway GP, Marinelli-Casey P, Stalcup J, Lord R, Christian D, Cohen J, Reiber C, Vandersloot D.
    J Psychoactive Drugs; 2000 Oct; 32(2):165-75. PubMed ID: 10908004
    [Abstract] [Full Text] [Related]

  • 8. The CSAT methamphetamine treatment program: research design accommodations for "real world" application.
    Huber A, Lord RH, Gulati V, Marinelli-Casey P, Rawson R, Ling W.
    J Psychoactive Drugs; 2000 Oct; 32(2):149-56. PubMed ID: 10908002
    [Abstract] [Full Text] [Related]

  • 9. The history and current state of drug abuse in Japan.
    Wada K.
    Ann N Y Acad Sci; 2011 Jan; 1216():62-72. PubMed ID: 21272011
    [Abstract] [Full Text] [Related]

  • 10. Methamphetamine abuse.
    Winslow BT, Voorhees KI, Pehl KA.
    Am Fam Physician; 2007 Oct 15; 76(8):1169-74. PubMed ID: 17990840
    [Abstract] [Full Text] [Related]

  • 11. DARK Classics in Chemical Neuroscience: Methamphetamine.
    Abbruscato TJ, Trippier PC.
    ACS Chem Neurosci; 2018 Oct 17; 9(10):2373-2378. PubMed ID: 29602278
    [Abstract] [Full Text] [Related]

  • 12. Methamphetamine for Hitler's Germany: 1937 to 1945.
    Defalque RJ, Wright AJ.
    Bull Anesth Hist; 2011 Apr 17; 29(2):21-4, 32. PubMed ID: 22849208
    [Abstract] [Full Text] [Related]

  • 13. Increasing morbidity and mortality associated with abuse of methamphetamine--United States, 1991-1994.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1995 Dec 01; 44(47):882-6. PubMed ID: 7476843
    [Abstract] [Full Text] [Related]

  • 14. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D, Greenberg MI, Miller SN, Okaneku JT, Haggerty DA.
    Dis Mon; 2012 Feb 01; 58(2):38-89. PubMed ID: 22251899
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients].
    Tanibuchi Y, Matsumoto T, Kobayashi O, Wada K.
    Seishin Shinkeigaku Zasshi; 2013 Feb 01; 115(5):463-76. PubMed ID: 23855225
    [Abstract] [Full Text] [Related]

  • 16. Smokable methamphetamine ('ice'): an old drug in a different form.
    Beebe DK, Walley E.
    Am Fam Physician; 1995 Feb 01; 51(2):449-53. PubMed ID: 7840041
    [Abstract] [Full Text] [Related]

  • 17. Distribution of methamphetamine and amphetamine in drug abusers' head hair.
    Lee S, Han E, Park Y, Choi H, Chung H.
    Forensic Sci Int; 2009 Sep 10; 190(1-3):16-8. PubMed ID: 19501481
    [Abstract] [Full Text] [Related]

  • 18. Methamphetamine and its impact on dental care.
    Klasser GD, Epstein J.
    J Can Dent Assoc; 2005 Nov 10; 71(10):759-62. PubMed ID: 16324229
    [Abstract] [Full Text] [Related]

  • 19. Ice--a new drug of concern?
    Beebe DK, Walley EJ.
    J Miss State Med Assoc; 1994 Aug 10; 35(8):225-7. PubMed ID: 7932687
    [Abstract] [Full Text] [Related]

  • 20. Treatment of methamphetamine use disorders: an update.
    Rawson RA, Gonzales R, Brethen P.
    J Subst Abuse Treat; 2002 Sep 10; 23(2):145-50. PubMed ID: 12220612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.